Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

September 2023

Propriétés différentielles des inhibiteurs de Janus Kinase dans le traitement des maladies inflammatoires à médiation immunitaire

Rheumatology (Oxford) 2023;63(2):298–308 doi 10.1093/rheumatology/kead448

Choy E,

Lippe R,

JAKis differ in structure, which affects their inhibitory concentration for different JAKs.

This review by Taylor, et al. compares the pharmacological profiles of JAKis, including abrocitinib, baricitinib, filgotinib, peficitinib, tofacitinib, and upadacitinib.

Keywords:

Le guselkumab modifie les gènes différentiellement exprimés dans le sang des patients atteints de rhumatisme psoriasique : Résultats de deux essais de phase 3, randomisés et contrôlés par placebo

ACR Open Rheumatol. 2023 doi: 10.1002/acr2.11589

Hsia EC,

Xu XL,

Song Q,

Gao S,

Chen W,

Miron M

Whole blood transcriptome profiling reveals differential gene expression in patients with active PsA from the DISCOVER-1 and DISCOVER-2 clinical studies in comparison with healthy controls.